NIRAJA PATEL: Open Payments
NPI 1780292987 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 12 payments from 9 companies in 2025. Trend: 2023 $31 · 2024 $103 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $124 |
| Pacira Pharmaceuticals Incorporated | 3 | $56 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $30 |
| HISTOSONICS, INC. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Alcresta Therapeutics, Inc. | 1 | $20 |
| Enterra Medical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Hollister Incorporated | 1 | $16 |
Products named: TREMFYA, Exparel, JOURNAVX, ZENPEP, RELIZORB, OMVOH, Hollister.
Industry payments across LA — which companies pay providers there.
